BONE GRAFT SUBSTITUTES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-148813 |   Healthcare

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Bone Graft Substitutes Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL BONE GRAFT SUBSTITUTES MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL BONE GRAFT SUBSTITUTES MARKET

7.1 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA BONE GRAFT SUBSTITUTES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 NovaBone Product, LLC.

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Exactech, Inc.

16.3 Medtronic Plc.

16.4 LifeNet Health

16.5 Zimmer Biomet Holdings, Inc.

16.6 Stryker Corporation.

16.7 BioHorizons Implant Systems, Inc.

16.8 Globus Medical, Inc.

16.9 RTI Surgical, Inc

16.10 Geistlich Pharma

16.11 Megagen

16.12 Novadip Biosciences

16.13 Mesoblast Ltd.

16.14 Alphatec Spine, Inc.

16.15 Institut Straumann AG

16.16 NuVasive, Inc.

16.17 OsteoMed LLC

16.18 KYERON Medical Innovations

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Product
Allografts
   o Demineralized Bone Matrix (DBM)
   o Others
Synthetic Bone Graft
Xenograft
Autograft
Others
By Material
Ceramic-based
   o Calcium Phosphate
   o Calcium Sulfate
Polymer-based
   o Polylactides
   o Polyglycolides
   o Polyurethanes
   o Others
Growth Factor-based
Cell-based
Others
By Application
Craniomaxillofacial
Dental
Foot & Ankle
Joint Reconstruction
Spinal Fusion
Long Bones
Others
By End User
Hospitals
Clinics
Ambulatory Care Centers
Academic & Research Institutes

Companies

NovaBone Product, LLC.
Exactech, Inc.
Medtronic Plc.
LifeNet Health
Zimmer Biomet Holdings, Inc.
Stryker Corporation.
BioHorizons Implant Systems, Inc.
Globus Medical, Inc.
RTI Surgical, Inc
Geistlich Pharma
Megagen
Novadip Biosciences
Mesoblast Ltd.
Alphatec Spine, Inc.
Institut Straumann AG
NuVasive, Inc.
OsteoMed LLC
KYERON Medical Innovations

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.